DiaMedica Therapeutics (DMAC) Free Cash Flow (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported Free Cash Flow of -$9.1 million for Q1 2026, down 27.19% on a YoY basis from -$12.5 million in Q1 2025, and down 17.25% quarter-over-quarter from -$7.8 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Free Cash Flow (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Free Cash Flow for 9 years, with the latest figure at -$9.1 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 27.19% year-over-year to -$9.1 million; the trailing twelve-month figure through Mar 2026 stood at -$31.0 million (down 37.38% YoY), and the FY2025 full-year result was -$29.1 million, down 31.68% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$9.1 million, down from -$7.8 million in the prior quarter.
- The five-year high for Free Cash Flow was -$2.4 million in Q3 2022, with the low at -$9.1 million in Q1 2026.
- Historically, Free Cash Flow has averaged -$5.3 million across 5 years, with a median of -$5.0 million in 2023.
- Annual changes were most pronounced in 2022 — Free Cash Flow climbed 21.13% — and 2023, when it tumbled 101.2%.
- DiaMedica Therapeutics' Free Cash Flow stood at -$2.8 million in 2022, then tumbled by 36.35% to -$3.8 million in 2023, then slumped by 68.83% to -$6.4 million in 2024, then retreated by 20.6% to -$7.8 million in 2025, then fell by 17.25% to -$9.1 million in 2026.
- The last three Free Cash Flow figures came in at -$9.1 million (Q1 2026), -$7.8 million (Q4 2025), and -$6.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 63,220.27 |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | -9.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.11 Mn |
| Mar 31, 2026 | -9.11 Mn |
| Dec 31, 2025 | -7.77 Mn |
| Dec 31, 2025 | -7.77 Mn |
| Sep 30, 2025 | -6.62 Mn |
| Sep 30, 2025 | -6.62 Mn |
| Jun 30, 2025 | -7.56 Mn |
| Jun 30, 2025 | -7.56 Mn |
| Mar 31, 2025 | -7.16 Mn |
| Mar 31, 2025 | -7.16 Mn |
| Dec 31, 2024 | -6.44 Mn |
| Dec 31, 2024 | -6.44 Mn |
| Sep 30, 2024 | -4.48 Mn |
| Sep 30, 2024 | -4.48 Mn |
| Jun 30, 2024 | -4.52 Mn |
| Jun 30, 2024 | -4.52 Mn |
| Mar 31, 2024 | -6.66 Mn |
| Mar 31, 2024 | -6.66 Mn |
| Dec 31, 2023 | -3.82 Mn |
| Dec 31, 2023 | -3.82 Mn |